Pacira BioSciences Inc (NASDAQ: PCRX) is 28.13% higher on its value in year-to-date trading and has touched a low of $11.16 and a high of $31.67 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PCRX stock was last observed hovering at around $23.82 in the last trading session, with the day’s gains setting it 0.32%.
Currently trading at $24.14, the stock is 1.52% and -0.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.11 million and changing 1.34% at the moment leaves the stock 20.08% off its SMA200. PCRX registered -18.09% loss for a year compared to 6-month gain of 64.78%. The firm has a 50-day simple moving average (SMA 50) of $24.2708 and a 200-day simple moving average (SMA200) of $20.1027.
The stock witnessed a -6.22% loss in the last 1 month and extending the period to 3 months gives it a 21.73%, and is 5.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.38% over the week and 4.71% over the month.
Pacira BioSciences Inc (PCRX) has around 790 employees, a market worth around $1.12B and $700.97M in sales. Fwd P/E is 6.66. Profit margin for the company is -14.20%. Distance from 52-week low is 116.23% and -23.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-8.25%).
with sales reaching $175.6M over the same period.The EPS is expected to shrink by -11.69% this year, but quarterly earnings will post 7.23% year-over-year. Quarterly sales are estimated to grow 5.08% in year-over-year returns.
Pacira BioSciences Inc (PCRX) Top Institutional Holders
316.0 institutions hold shares in Pacira BioSciences Inc (PCRX), with institutional investors hold 115.68% of the company’s shares. The shares outstanding are 46.24M, and float is at 44.24M with Short Float at 13.25%. Institutions hold 112.00% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.01 million shares valued at $229.08 million. The investor’s holdings represent 17.3406% of the PCRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.08 million shares valued at $145.48 million to account for 11.0123 of the shares outstanding. The other top investors are PACER ADVISORS, INC. which holds 2.16 million shares representing 4.684% and valued at over $61.88 million, while RENAISSANCE TECHNOLOGIES LLC holds 4.4748 of the shares totaling 2.07 million with a market value of $59.11 million.
Pacira BioSciences Inc (PCRX) Insider Activity
#####
Pacira BioSciences Inc disclosed in a document filed with the SEC on Jan 06 ’25 that SLONIN JONATHAN (Chief Medical Officer) sold a total of 879 shares of the company’s common stock. The trade occurred on Jan 06 ’25 and was made at $18.40 per share for $16174.0. Following the transaction, the insider now directly holds 93444.0 shares of the PCRX stock.
Still, SEC filings show that on Jan 06 ’25, SLONIN JONATHAN (Officer) Proposed Sale 879 shares at an average price of $18.40 for $16174.0. The insider now directly holds shares of Pacira BioSciences Inc (PCRX).
